SAN DIEGO and TORONTO, Oct. 19, 2020 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated agents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback